Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 14/20 | 0.64 |
| ▸ | BACE2 | Q9Y5Z0 | 3/20 | 0.61 |
| ▸ | NPY1R | P25929 | 1/20 | 0.58 |
| ▸ | NPY2R | P49146 | 1/20 | 0.58 |
| ▸ | NPY4R | P50391 | 1/20 | 0.58 |
| ▸ | CTSD | P07339 | 1/20 | 0.57 |
| ▸ | KISS1R | Q969F8 | 4/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18670433 | 1.00 | BACE1 (0.64) | BACE1BACE2NPY1RNPY2RNPY4R | |
| SCHEMBL34471860 | 0.95 | BACE1 (0.67) | BACE1BACE2NPY1RNPY2RNPY4R | |
| SCHEMBL29397496 | 0.95 | BACE1 (0.63) | BACE1BACE2NPY1RNPY2RNPY4R | |
| SCHEMBL31711265 | 0.93 | BACE1 (0.58) | BACE1BACE2NPY1RNPY2RNPY4R | |
| SCHEMBL29440807 | 0.92 | NPY1R (0.59) | BACE1BACE2NPY1RNPY2RNPY4R | |
| SCHEMBL29549531 | 0.92 | BACE1 (0.60) | BACE1BACE2NPY1RNPY2RNPY4R | |
| SCHEMBL30446943 | 0.92 | NPY1R (0.58) | BACE1BACE2NPY1RNPY2RNPY4R | |
| SCHEMBL4208913 | 0.92 | BACE1 (0.59) | BACE1BACE2NPY1RNPY2RNPY4R | |
| SCHEMBL4208920 | 0.92 | BACE1 (0.59) | BACE1BACE2NPY1RNPY2RNPY4R | |
| SCHEMBL29730544 | 0.91 | NPY4R (0.58) | BACE1BACE2NPY1RNPY2RNPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023205728-A2 | SOLUBLE SINGLE-CHAIN DIMERS FROM CLEAVABLE SINGLE CHAIN TRIMERS | INSTITUTE FOR SYSTEMS BIOLOGY (US) | 2023-10-26 | — | — | WO | claimed |
| EP-4748447-A2 | INFLUENZA VIRUS VACCINES AND USES THEREOF | Icahn School of Medicine at Mount Sinai (US) | 2026-05-27 | — | — | EP | disclosed |
| US-20260092925-A1 | IMPROVED FLUORESCENT PROTEINS | NUCLERA LTD (GB) | 2026-04-02 | — | — | US | disclosed |
| US-20260071227-A1 | METHOD FOR SECRETORY PRODUCTION OF PROTEINS | AJINOMOTO CO., INC. (JP) | 2026-03-12 | — | — | US | disclosed |
| US-20260048114-A1 | INFLUENZA VIRUS VACCINATION REGIMENS | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2026-02-19 | — | — | US | disclosed |
| EP-4241785-B1 | INFLUENZA VIRUS VACCINES AND USES THEREOF | ICAHN SCHOOL MED MOUNT SINAI (US) | 2026-01-28 | — | — | EP | disclosed |
| US-20260001918-A1 | INFLUENZA VIRUS VACCINES AND USES THEREOF | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2026-01-01 | — | — | US | disclosed |
| US-20260000747-A1 | INFLUENZA VIRUS VACCINES AND USES THEREOF | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2026-01-01 | — | — | US | disclosed |
| EP-4667580-A1 | METHOD FOR SECRETORY PRODUCTION OF PROTEINS | AJINOMOTO CO., INC. (JP) | 2025-12-24 | — | — | EP | disclosed |
| US-20250382608-A1 | LINEAR NUCLEIC ACID EXPRESSION CONSTRUCTS | NUCLERA LTD (GB) | 2025-12-18 | — | — | US | disclosed |
| US-20220056104-A1 | MATERIALS AND METHODS OF USING ENGINEERED LIGANDS | JANSSEN BIOTECH, INC. (US) | 2022-02-24 | — | — | US | disclosed |
| US-11254733-B2 | Anti-influenza B virus neuraminidase antibodies and uses thereof | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2022-02-22 | — | — | US | disclosed |
| CN-109957560-B | Polypeptide with protease activity and application thereof | 清华大学 | 2021-06-29 | — | — | CN | disclosed |
| US-20210017402-A1 | ANTI-FOULING PAINTS AND COATINGS | REACTIVE SURFACES, LTD., LLP (US) | 2021-01-21 | — | — | US | disclosed |
| US-20200354588-A1 | ANTI-FOULING PAINTS AND COATINGS | REACTIVE SURFACES, LTD., LLP (US) | 2020-11-12 | — | — | US | disclosed |
| US-20190203227-A1 | LIGHT-CONTROLLED GENE DELIVERY WITH VIRUS VECTORS THROUGH INCORPORATION OF OPTOGENETIC PROTEINS AND GENETIC INSERTION OF NON-CONFORMATIONALLY CONSTRAINED PEPTIDES | WILLIAM MARSH RICE UNIVERSITY | 2019-07-04 | — | — | US | disclosed |
| CN-109957560-A | A kind of polypeptide and its application with proteinase activity | 清华大学 | 2019-07-02 | — | — | CN | disclosed |
| WO-2017053629-A2 | LIGHT-CONTROLLED GENE DELIVERY WITH VIRUS VECTORS THROUGH INCORPORATION OF OPTOGENETIC PROTEINS AND GENETIC INSERTION OF NON-CONFORMATIONALLY CONSTRAINED PEPTIDES | WILLIAM MARSH RICE UNIVERSITY (US) | 2017-03-30 | — | — | WO | disclosed |
| US-20140083324-A1 | Anti-fouling Paints and Coatings | REACTIVE SURFACES, LTD (US) | 2014-03-27 | — | — | US | disclosed |
| US-20110070376-A1 | Anti-fouling Paints & Coatings | REACTIVE SURFACES, LTD. (US) | 2011-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071227-A1 | METHOD FOR SECRETORY PRODUCTION OF PROTEINS | MDH1, MDH2, MLYCD | BACE1 4149/4885BACE2 3853/4885NPY1R 1972/4885 |
| US-20260092925-A1 | IMPROVED FLUORESCENT PROTEINS | YIPF5, YIF1A, GTF3C5 | BACE1 3741/4885BACE2 3332/4885NPY1R 460/4885 |
| US-20260000747-A1 | INFLUENZA VIRUS VACCINES AND USES THEREOF | H1-3, H1-4, H1-2 | BACE1 1919/4885BACE2 2429/4885NPY1R 2515/4885 |
| US-20260048114-A1 | INFLUENZA VIRUS VACCINATION REGIMENS | H1-3, CD81, FUT8 | BACE1 1299/4885BACE2 1531/4885NPY1R 4375/4885 |
| US-20250382608-A1 | LINEAR NUCLEIC ACID EXPRESSION CONSTRUCTS | RNGTT, RNMT, MRPS27 | BACE1 4536/4885BACE2 3949/4885NPY1R 4693/4885 |
| US-20260001918-A1 | INFLUENZA VIRUS VACCINES AND USES THEREOF | CD44, SIGLEC7, SIGLEC9 | BACE1 1465/4885BACE2 2251/4885NPY1R 3267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.